Biopharma Layoff Tracker 2024: Staff Reductions at Perrigo, Denali, Galapagos, and Other Companies.

The biopharma sector faced significant challenges in 2023, as numerous companies underwent workforce downsizing and restructuring efforts in a bid to remain viable. While there are indications of improvement, with PwC forecasting a "healthy" level of mergers and acquisitions in the pharmaceutical and life sciences sectors for 2024, the question remains: Will the job market reflect this positive trend?

BioSpace remains committed to providing you with the latest news on job cuts and restructuring initiatives throughout 2024. Stay informed as we keep you updated on companies tightening their budgets and reducing staff.